News ArticleGlenmark Pharmaceuticals Releases Audio Recording of Q2 FY 2026-27 Earnings Call Held on November 6, 2026
The company uploaded the call audio on its website in compliance with SEBI regulations for shareholder transparency
Glenmark Pharmaceuticals Limited announced the availability of the audio recording of its Q2 FY 2026-27 earnings call held on November 6, 2026, providing investors and stakeholders access to detailed quarterly financial discussions via the company website.
Glenmark Pharmaceuticals Limited
Earnings Call Transcript
Glenmark Pharmaceuticals Limited has made available the audio recording of its Q2 FY 2026-27 earnings call held on November 6, 2026, enabling investors to review insights and discussions on the quarterly financial performance.
The earnings call focused on the company's financial results for the second quarter of fiscal year 2026-27.
The audio recording is accessible through the Glenmark Pharmaceuticals official website, enhancing disclosure and investor engagement.
The company provided this update in accordance with SEBI Listing Obligations and Disclosure Requirements Regulations 2015, fulfilling regulatory requirements for prompt and transparent dissemination of financial information.
Highlights
- Earnings call for Q2 FY 2026-27 held on November 6, 2026.
- Audio recording uploaded at https://glenmark.b-cdn.net/gpl_pdfs/Financials/Quarterly/10048515.mp3.
- Filing complies with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- Supports timely investor access to company’s quarterly financial discussions.
Key Data Snapshot
What happened
- Glenmark Pharmaceuticals conducted its Q2 FY 2026-27 earnings conference call on November 6, 2026.
- The company uploaded the audio recording of the call on its official website for stakeholder access.
- This disclosure aligns with SEBI regulations requiring listed companies to timely share material investor communications.
Regulatory and governance context
- The announcement complies with Regulation 30 and 46 along with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), 2015.
- Such filings ensure transparent communication between the company and its investors regarding quarterly financial performance and discussions.
Highlights
- Earnings call for Q2 FY 2026-27 held on November 6, 2026.
- Audio recording uploaded at https://glenmark.b-cdn.net/gpl_pdfs/Financials/Quarterly/10048515.mp3.
- Filing complies with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- Supports timely investor access to company’s quarterly financial discussions.
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- Regulation 30 and 46
- Part A of Schedule III
More News on Earnings Call Transcript
View allLatest corporate announcements and market updates in Earnings Call Transcript.
Go Digit General Insurance Hosts Earnings Call Recording for Q2 and H1 FY2026-27
Go Digit General Insurance Limited has made the recorded earnings call for the quarter and half-year ended 30th September 2026 available on its website, providing investors access to the company's financial discussion held on 5th November 2026.
Read Full Story
Thermax Limited Releases Audio Recording of November 6, 2026 Investor Conference Call on Quarterly Results
Thermax Limited has published the audio recording of its investor conference call held on November 6, 2026, which discussed the latest quarterly financial results. The recording is accessible on the company’s official investor relations webpage.
Read Full Story
Navin Fluorine International Reports INR500 Crores PAT in H1 FY27 and Extends Solstice Supply Contract to 2032
Navin Fluorine International Limited announced a profit after tax exceeding INR500 crores and an EPS of INR100 for the first half of fiscal year 2027. The company declared an interim dividend of INR8 per equity share and extended its existing hydrogen fluoride supply contract with Solstice Advanced Materials by four years until December 2032, unlocking additional revenue potential of approximately USD 180 million.
Read Full Story
